↓ Skip to main content

American Association for Cancer Research

Navitoclax (ABT-263) Reduces Bcl-xL–Mediated Chemoresistance in Ovarian Cancer Models

Overview of attention for article published in Molecular Cancer Therapeutics, April 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent
5 patents

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
77 Mendeley
citeulike
1 CiteULike